Header Logo

Connection

HUSSEIN TAWBI to Antigens, CD

Back to Details
This is a "connection" page, showing publications HUSSEIN TAWBI has written about Antigens, CD.
HUSSEIN TAWBI
Connection Strength
0.191
Antigens, CD
  1. Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma. N Engl J Med. 2022 01 06; 386(1):24-34.
    View in: PubMed
    Score: 0.144
  2. Targeted Therapies in Cancer - Fourth International Congress. Epidermal growth factor receptor blockade and immune modulation. IDrugs. 2005 Dec; 8(12):987-9.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.